Alveus Therapeutics
PrivateLast Round
Series A
Extension
Feb 24, 2026
Total Funding Raised
$196.8M
Company Overview
Alveus Therapeutics is a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alveus Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Alveus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 24, 2026 | ||||
| Series A | Jan 8, 2026 |
Alveus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | Series A, Series A Extension |
| Andera Partners | Series A, Series A Extension |
| New Rhein Healthcare Investors | Series A, Series A Extension |
| Avego BioScience Capital | Series A, Series A Extension |
| Novo Holdings | Series A Extension |
| Sanofi Ventures | Series A Extension |
| Jeito | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 29, 2026
Developing new active ingredient for obesity treatment with InterAx.
- Jan 29, 2026
Partnered with InterAx to develop an obesity treatment active ingredient.
Alveus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alveus Therapeutics's valuation, stock price, and market status.
